Age-related macular degeneration histopathologic studies. The 1992 Lorenz E. Zimmerman Lecture.
about
Cholesterol-enriched diet causes age-related macular degeneration-like pathology in rabbit retinaSPACRCAN, a novel human interphotoreceptor matrix hyaluronan-binding proteoglycan synthesized by photoreceptors and pinealocytesSystemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degenerationBestrophin, the product of the Best vitelliform macular dystrophy gene (VMD2), localizes to the basolateral plasma membrane of the retinal pigment epitheliumThe expression of advanced glycation endproduct receptors in rpe cells associated with basal deposits in human maculasRegulation of signaling events involved in the pathophysiology of neovascular AMDClinical applications of optical coherence tomography in the posterior pole: the 2011 José Manuel Espino Lecture - Part IIToday and future of age-related macular degenerationThe proteomics of drusenAnimal models of age related macular degenerationCrystal structure of the globular domain of C1QTNF5: Implications for late-onset retinal macular degenerationGeographic Atrophy and Choroidal Neovascularization in the Same Eye: A ReviewThe stereotypical molecular cascade in neovascular age-related macular degeneration: the role of dynamic reciprocityClinicopathological correlation of retinal pigment epithelial tears in exudative age related macular degeneration: pretear, tear, and scarred tearTreatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapyPassive permeability and outward active transport of fluorescein across the blood-retinal barrier in early ARMThe Project MACULA Retinal Pigment Epithelium Grading System for Histology and Optical Coherence Tomography in Age-Related Macular DegenerationCD36 deficiency leads to choroidal involution via COX2 down-regulation in rodentsSpectral-domain optical coherence tomography findings in polypoidal choroidal vasculopathy suggest a type 1 neovascular growth pattern.Is reduction in the risk of vision loss the only benefit of photodynamic therapy in predominantly classic subfoveal choroidal neovascularization?The Evolution of the Plateau, an Optical Coherence Tomography Signature Seen in Geographic Atrophy.Improved contrast of subretinal structures using polarization analysisRetinal topography and thickness mapping in atrophic age related macular degeneration.The relative contributions of each subset of ocular infiltrated cells in experimental choroidal neovascularisation.Relationship between foveal birefringence and visual acuity in neovascular age-related macular degeneration.Ultrahigh resolution optical coherence tomography in non-exudative age related macular degenerationPhase I clinical trial results of verteporfin enhanced feeder vessel therapy in subfoveal choroidal neovascularisation in age related macular degenerationAge-related macular degeneration--emerging pathogenetic and therapeutic concepts.Emerging therapies for the treatment of neovascular age-related macular degeneration and diabetic macular edema.Retinal angiomatous proliferation: combined therapy of intravitreal triamcinolone acetonide and PDT versus PDT alone.Clinical features of early and late stage polypoidal choroidal vasculopathy characterized by lesion size and disease duration.Dynamic indocyanine green angiography-guided focal thermal laser treatment of fibrotic choroidal neovascularization.Chronic cigarette smoke causes oxidative damage and apoptosis to retinal pigmented epithelial cells in mice.Isolation and characterization of a spontaneously immortalized bovine retinal pigmented epithelial cell line.Current and emerging therapies for the treatment of age-related macular degenerationAbundant lipid and protein components of drusenApolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration.The role of RPE cell-associated VEGF₁₈₉ in choroidal endothelial cell transmigration across the RPE.Foveal-Sparing Scotomas in Advanced Dry Age-Related Macular DegenerationComparing fixation location and stability in patients with neovascular age-related macular degeneration treated with or without Ranibizumab
P2860
Q21260371-C1F9E98A-065F-4B4B-97D4-4B3F145B1DDEQ22253277-1F196CA3-B300-4288-B264-19382EA664BAQ24193614-DF8469BE-9ADB-461E-B5AA-062686868F2CQ24290436-DA99BAD7-71F1-4C56-B533-6BCC332C337CQ24602544-746052DA-FD5A-457A-A4B3-9EAADE6129C7Q26751293-4CD51AE4-AADB-4D60-807C-7E482666CCC2Q26864721-588364CF-F6B4-46E6-A078-1B59A1C2767CQ26865643-654BCD9D-A9B0-4E3C-9237-B19173D1708AQ26997523-F9DC7A8C-6FED-48E7-B0A5-6788530A3FBDQ27004686-C175CD4B-F855-4F07-96D1-354BBBE6B1BBQ27671548-6F5C09F6-7069-42C2-96F0-964B52FE53B6Q28074640-0FFF99CD-1FD2-4D9C-85F7-A7A9BF45A773Q28085495-B9F0631E-1A92-4557-9C7F-943B42879DDBQ28361122-5036F70E-488B-477F-B735-3D8A0C83F2C1Q28361141-8CA0B3CF-AF96-4BA8-954B-95A2023000B0Q28363461-92949E11-A2B4-4DAE-AE4A-57610F3D79FBQ28645952-EC6E5124-F051-48DA-AFCA-478CD04457D1Q28755557-91301AF2-0FD9-4357-8DD1-4B32AE1D68B4Q30410747-07DC14AE-A9FA-41B5-8D89-37DECE6AE6F1Q30438969-B0DF95D0-2268-4932-BF7B-D7296877F6EEQ30847480-0F896A2B-F592-4FF8-8D48-0D51D20FE2C8Q30978469-AD037323-F09E-40B7-A72A-005C59ECECAFQ31063190-6D9163D9-EDA4-4286-9390-0B7B16F5644AQ33206080-11BCF3C6-7CF7-4850-9439-227C402F178DQ33231055-80334069-E1D3-4423-851A-CA15A67D346CQ33232109-066A5FEC-4E49-40C4-A610-20C320EEA1F2Q33246808-4741881D-A329-452E-8869-5F0D01C62F08Q33263472-062E783B-B054-43D4-8A2D-7F092FA01813Q33290721-E53C0604-2B36-4315-BBFA-1B358E3B4323Q33292976-227F374D-882F-4326-9C17-856722CEF63EQ33301645-DF23291A-D08B-4464-8D98-73C0FECF8489Q33358167-E6520030-3608-424C-989F-9FDEABC05405Q33366509-44EF1D3F-9079-46CB-8642-D9C5DB25FA21Q33438689-4061E42F-422E-45CF-AD7D-EBC33E05DD14Q33492370-D3E37714-752F-4773-A2D0-DF93866BA7D2Q33567644-8D27F54E-EC89-41E2-B0EF-00C6FECDFFADQ33634096-28AA75A6-BEFD-4D32-A35C-CBFE95252012Q33681817-4FD66DB4-FE83-47E2-A451-5D5EEE288171Q33717354-3FB83549-D015-4D3C-9F38-FE2A8C159841Q33753878-E854862A-C4D3-4E57-B3F0-888F5B84E958
P2860
Age-related macular degeneration histopathologic studies. The 1992 Lorenz E. Zimmerman Lecture.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Age-related macular degenerati ...... 2 Lorenz E. Zimmerman Lecture.
@en
Age-related macular degenerati ...... 2 Lorenz E. Zimmerman Lecture.
@nl
type
label
Age-related macular degenerati ...... 2 Lorenz E. Zimmerman Lecture.
@en
Age-related macular degenerati ...... 2 Lorenz E. Zimmerman Lecture.
@nl
prefLabel
Age-related macular degenerati ...... 2 Lorenz E. Zimmerman Lecture.
@en
Age-related macular degenerati ...... 2 Lorenz E. Zimmerman Lecture.
@nl
P1433
P1476
Age-related macular degenerati ...... 2 Lorenz E. Zimmerman Lecture.
@en
P2093
P304
P356
10.1016/S0161-6420(93)31466-1
P577
1993-10-01T00:00:00Z